Journal article
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee
Abstract
BACKGROUND: Quality of life and patient reported outcome measures (PROMs) are important secondary endpoints and incorporated in most contemporary clinical trials. There have been deficiencies in their assessment and reporting in ovarian cancer clinical trials, particularly in trials of maintenance treatment where they are of particular importance. The Gynecologic Cancer InterGroup (GCIG) symptom benefit committee (SBC) recently convened a …
Authors
Kurtz J-E; Gebski V; Sukhin V; Carey M; Kong I; Glasspool RM; Berek JS; de Paiva Batista M; Hall M; Kim J-W
Journal
Gynecologic Oncology, Vol. 161, No. 2, pp. 502–507
Publisher
Elsevier
Publication Date
5 2021
DOI
10.1016/j.ygyno.2021.02.018
ISSN
0090-8258